Evidence map›Paper›PMID 39609617›Full record

ArticleCommunications biology2024

Evolutionary genomics of Leishmania braziliensis across the neotropical realm.

Senne Heeren, Mandy Sanders, Jeffrey Jon Shaw, Sinval Pinto Brandão-Filho, Mariana Côrtes Boité, Lilian Motta Cantanhêde, Khaled Chourabi, Ilse Maes, Alejandro Llanos-Cuentas, Jorge Arevalo and 6 more

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Unraveling the Genome Diversity ofLife (Basel, Switzerland) · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Impact of 2D versus 3D fibroblast models onFrontiers in cellular and infection microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Senne HeerenDepartment of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. sheeren@itg.be.ORCID 0000-0002-5786-258X
Mandy SandersWelcome Sanger Institute, Hinxton, United Kingdom.
Jeffrey Jon ShawDepartamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de São Paulo (USP), São Paulo, Brazil.
Sinval Pinto Brandão-FilhoDepartment of Immunology, Aggeu Magalhães Institute, Fiocruz, Brazil.
Mariana Côrtes BoitéLeishmaniasis Research Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID 0000-0002-2903-6280
Lilian Motta CantanhêdeLeishmaniasis Research Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Khaled ChourabiLeishmaniasis Research Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID 0000-0001-8722-6288
Ilse MaesDepartment of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Alejandro Llanos-CuentasInstituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID 0000-0002-7567-5534
Jorge ArevaloInstituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
Jorge D MarcoInstituto de Patología Experimental, Universidad Nacional de Salta-Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Salta, Argentina.ORCID 0000-0002-4408-0941
Philippe LemeyDepartment of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium.ORCID 0000-0003-2826-5353
James A CottonWelcome Sanger Institute, Hinxton, United Kingdom.ORCID 0000-0001-5475-3583
Jean-Claude DujardinDepartment of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0002-9217-5240
Elisa Cupolillo *Leishmaniasis Research Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. elisa.cupolillo@ioc.fiocruz.br.ORCID 0000-0002-0620-3250
Frederik Van den Broeck *Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. fvandenbroeck@gmail.com.ORCID 0000-0003-2542-5585

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Brazilian Federal Agency for the Support and Evaluation of Graduate Education) Finance Code 001Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 1226120NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G092921NFundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro) 205.731/2022Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro) E_ 08/2020 -COLBIO-210.285/2021Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro) E26-202.569/2019Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro) E-26/205.730/2022Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (National Council for Scientific and Technological Development) 302622/2017-9Wellcome Trust 206194
6 · The paper itself

Abstract

The Neotropical realm, one of the most biodiverse regions on Earth, houses a broad range of zoonoses that pose serious public health threats. Protozoan parasites of the Leishmania (Viannia) braziliensis clade cause zoonotic leishmaniasis in Latin America with clinical symptoms ranging from simple cutaneous to destructive, disfiguring mucosal lesions. We present the first comprehensive genome-wide continental study including 257 cultivated isolates representing most of the geographical distribution of this major human pathogen. The L. braziliensis clade is genetically highly heterogeneous, consisting of divergent parasite groups that are associated with different environments and vary greatly in diversity. Apart from several small ecologically isolated groups with little diversity, our sampling identifies two major parasite groups, one associated with the Amazon and the other with the Atlantic Forest biomes. These groups show different recombination histories, as suggested by high levels of heterozygosity and effective population sizes in the Amazonian group in contrast to high levels of linkage and clonality in the Atlantic group. We argue that these differences are linked to strong eco-epidemiological differences between the two regions. In contrast to geographically focused studies, our study provides a broad understanding of the molecular epidemiology of zoonotic parasites circulating in tropical America.

Indexed as

Leishmania braziliensisAnimalsEvolution, MolecularGenetic VariationGenome, ProtozoanGenomicsHumansLeishmaniasis, CutaneousPhylogeny

Identifiers

PMID39609617
PMCPMC11605123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.